News
SurvivorNet on MSN12h
New Hope for Patients With Advanced Lung Cancer: Datroway, A New FDA ApprovalA new treatment option, Datroway (datopotamab deruxtecan or Dato-DXd), is now available for people with non-small cell lung ...
In a small cell therapy trial, 10 out of 12 people with type 1 diabetes no longer needed supplemental insulin, even a year after treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback